Company: XAIR
Filing Date: 2025-02-14
Form Type: 424B5
Source: 0001493152-25-006903
Chunk: 0

Company: Beyond Air, Inc.
Filing Date: 2025-02-14
Form: 424B5
Chunk 0
---
Filed Pursuant to Rule 424(b)(5)

Registration No. 333-284653

PROSPECTUS SUPPLEMENT

(To Prospectus dated February 10, 2025)

<div align='center'>$9,892,518

Beyond Air, Inc.

Common Stock</div>

We have entered into a sales agreement with BTIG, LLC, or BTIG, who we refer to as the agent, relating to shares of our common stock offered by this prospectus supplement. In accordance with the terms of the sales agreement, we may offer and sell shares of our common stock having an aggregate offering price of up to $35,000,000 from time to time through the agent. However, due to the offering limitations applicable to us under General Instruction I.B.6. of Form S-3 and our public float calculated in accordance therewith as of the date of this prospectus supplement, and in accordance with the terms of the sales agreement, we are offering shares of our common stock having an aggregate gross sales price of up to $9,892,518 pursuant to this prospectus supplement and the accompanying prospectus. If our public float increases such that we may sell additional amounts under the sales agreement and the registration statement of which this prospectus supplement and the accompanying prospectus are a part, we will file another prospectus supplement prior to making additional sales.

Our common stock is listed on the Nasdaq Capital Market under the symbol “XAIR.” On February 13, 2025, the last reported sales price for our common stock was $0.37 per share.

Sales of our common stock, if any, under this prospectus supplement may be made in sales deemed to be “at the market offerings” as defined in Rule 415 promulgated under the Securities Act of 1933, as amended, or the Securities Act, including sales made directly on or through the Nasdaq Capital Market, the existing trading market for our common stock, or any other existing trading market for our common stock. The agent is not required to sell any specific number or dollar amount of securities, but will act as sales agent, using commercially reasonable efforts consistent with its normal trading and sales practices, on mutually agreed terms between the agent and us. There is no arrangement for funds to be received in any escrow, trust or similar arrangement.

The compensation to the agent for sales of common stock sold pursuant to the sales agreement will be an amount up to 3.0% of the gross proceeds of any shares of common stock sold